ANDROSKI LINDSAY (President and CEO) received a stock award from ARBUTUS BIOPHARMA CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/2/2026ACC: 0001447028-26-000008
DirectorOfficer· President and CEO
Since Feb 2026
+99.70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
99.70K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+28K
Price / share
—
Trade value
—
% of position
New position
2/2/2026
0.00→28K
Total
Net shares
+28K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/2/2026 | A · Award | +28K | — | — | New position | 0.00 | 28K |
| Total | +28K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
71.70K shares
Shares
+71.70K
Strike price
4.39
Held after
71.70K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares71.70K shares | 2/2/2026 | A · Award | +71.70K | 4.39 | — | 71.70K |